The head of the Arizona Cancer Evolution Center proposes fighting tumor resistance with adaptive therapy: administering drugs at the lowest effective dose
Suffering from prostate cancer or benign prostatic hyperplasia (BPH) is not the end of a relationship. Technology and sexologists offer solutions to maintain erections and orgasms, even if ejaculation is no longer possible
The geneticist speaks with EL PAÍS about the advances and challenges in the field of cancer research
The American Society of Clinical Oncology shows power of molecular alterations in guiding treatment and determining prognosis
The physician says she is worried about the rise in early-onset tumors and laments inequalities between countries in access to cancer treatments
Adolescents aged 15 to 19 and women of all ages are the worst affected, especially by anxiety and depression
The Spanish scientist works at Altos Labs, a secretive US biotech company funded by billionaires seeking to eliminate the effects of aging
A cancer survivor living with diabetes, the 69‑year‑old worker speaks exclusively to EL PAÍS about her struggle to collect the settlement owed to her as the singer’s longtime assistant, after he removed her from his team in 2017 without explanation
A team led by Spaniard David Lagares is searching for a treatment for pulmonary fibrosis and other ailments associated with cellular senescence
The Argentine scientist, who discovered molecular switches that regulate the immune response, is a senior researcher at the new CaixaResearch Institute in Barcelona
Miriam González, a Spanish engineer, has a rare breast tumor. Her experience illustrates the complexity of using AI effectively, as these tools tend to struggle with basic medical questions
A study confirms a new case of long‑term remission following a stem cell transplant from a donor with a unique genetic mutation
Utilizing newborn blood is more of a dream than a reality, and storing it in public banks is largely for a potential greater good
A study in ‘The Lancet’ says that besides biological factors such as sperm quality, sociocultural variables also influence offspring
The American professor has spent 30 years studying the social brain. He speaks with EL PAÍS about the loneliness epidemic, specifically how artificial intelligence and political polarization might influence it
The head of the Radiotherapy Oncology department at La Fe Hospital in Valencia believes that proton therapy will put the Spanish public system at the forefront of Europe’s fight against cancer
The tool displays organs in three dimensions and opens new avenues for researching key diseases, such as cancer and diabetes
After learning that they carry a mutated version of the BRCA1 gene, their options were to undergo intensive monitoring every six months or to have preventive surgeries involving profound changes to their bodies and their lives
A study reveals that the rate of new cases in those over 55, who still make up the majority, remains stable, but diagnoses are increasing at younger ages
Live fast, die old. This could be the premise of the work by this researcher, who tries to unravel the secrets of centenarians who are in good health despite a lifestyle that cannot always be considered a model to follow
The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of leukemias and lymphomas
A study identifies rare variants in a gene associated with reduced tobacco consumption
Scientist Laura Soucek, who removed tumors from rodents almost 20 years ago, invokes the ‘moral duty’ not to generate false expectations after Mariano Barbacid’s announcement
The scientist is author of one of the most influential works in the history of tumor research
‘It seemed deeply unfair that in this era of precision medicine, where targeted therapies are the treatment of choice for cancer in humans, they didn’t exist for cats,’ says the senior author of the study
The model allows for the precise and complex modification of cells and molecules to cure diseases
The biochemist’s company, Vega Oncotargets, has toned down its message after the false expectations generated by the announcement of a promising experiment with 45 ‘cured’ mice
